A. Bruzzaniti and R. Baron, Molecular regulation of osteoclast activity, Reviews in Endocrine and Metabolic Disorders, vol.4, issue.6, pp.123-139, 2006.
DOI : 10.1007/s11154-006-9009-x

S. Theoleyre, Y. Wittrant, K. Tat, S. Fortun, Y. Redini et al., The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling, Cytokine & Growth Factor Reviews, vol.15, issue.6, pp.457-475, 2004.
DOI : 10.1016/j.cytogfr.2004.06.004

D. Heymann, J. Guicheux, F. Gouin, N. Passuti, and G. Daculsi, CYTOKINES, GROWTH FACTORS AND OSTEOCLASTS, Cytokine, vol.10, issue.3, pp.155-168, 1998.
DOI : 10.1006/cyto.1997.0277

M. Baud-'huin, F. Lamoureux, L. Duplomb, F. Rédini, and D. Heymann, RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases, Cell Mol Life Sci, vol.64, pp.2334-2350, 2007.

A. Rousselle and D. Heymann, Osteoclastic acidification pathways during bone resorption, Bone, vol.30, issue.4, pp.533-540, 2002.
DOI : 10.1016/S8756-3282(02)00672-5

S. Georges, R. Velasco, C. Trichet, V. Fortun, Y. Heymann et al., Proteases and bone remodelling, Cytokine & Growth Factor Reviews, vol.20, issue.1, pp.29-41, 2009.
DOI : 10.1016/j.cytogfr.2008.11.005

P. Marie and O. Fromigué, Osteogenic differentiation of human marrow-derived mesenchymal stem cells, Regenerative Medicine, vol.1, issue.4, pp.539-548
DOI : 10.2217/17460751.1.4.539
URL : https://hal.archives-ouvertes.fr/inserm-00146192

C. Damiens, Y. Fortun, C. Charrier, D. Heymann, and M. Padrines, MODULATION BY SOLUBLE FACTORS OF GELATINASE ACTIVITIES RELEASED BY OSTEOBLASTIC CELLS, Cytokine, vol.12, issue.11, pp.1727-1731, 2000.
DOI : 10.1006/cyto.2000.0765

F. Lamoureux, M. Baud-'huin, L. Duplomb, D. Heymann, and F. Rédini, Proteoglycans: key partners in bone cell biology, BioEssays, vol.53, issue.8, pp.758-771, 2007.
DOI : 10.1002/bies.20612

W. Boyle, W. Simonet, and D. Lacey, Osteoclast differentiation and activation, Nature, vol.34, issue.6937, pp.337-342, 2003.
DOI : 10.1007/s007740200049

Y. Wittrant, S. Theoleyre, S. Couillaud, C. Dunstan, D. Heymann et al., Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities, Experimental Cell Research, vol.293, issue.2, pp.292-301, 2004.
DOI : 10.1016/j.yexcr.2003.10.016

H. Yasuda, N. Shima, N. Nakagawa, S. Mochizuki, K. Yano et al., Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro, Endocrinology, vol.139, issue.3, pp.1329-1337, 2004.
DOI : 10.1210/en.139.3.1329

F. Lamoureux, M. Baud-'huin, L. Duplomb, D. Heymann, and F. Rédini, Proteoglycans: key partners in bone cell biology, BioEssays, vol.53, issue.8, pp.758-771, 2007.
DOI : 10.1002/bies.20612

A. Corsi, T. Xu, X. Chen, A. Boyde, J. Liang et al., Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers-Danlos-Like Changes in Bone and Other Connective Tissues, Journal of Bone and Mineral Research, vol.87, issue.Suppl V, pp.1180-1189, 2002.
DOI : 10.1359/jbmr.2002.17.7.1180

L. Duplomb, M. Dagouassat, P. Jourdon, and D. Heymann, Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation, STEM CELLS, vol.143, issue.3, pp.544-552, 2007.
DOI : 10.1634/stemcells.2006-0395

W. Raschke, S. Baird, P. Ralph, and I. Nakoinz, Functional macrophage cell lines transformed by abelson leukemia virus, Cell, vol.15, issue.1, pp.261-267, 1978.
DOI : 10.1016/0092-8674(78)90101-0

S. Theoleyre, Y. Wittrant, S. Couillaud, P. Vusio, M. Berreur et al., Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor ??B ligand and MAPK, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1644, issue.1, pp.1-7, 2004.
DOI : 10.1016/j.bbamcr.2003.10.005

C. Blin-wakkach, V. Breuil, D. Quincey, C. Bagnis, and G. Carle, Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice, Bone, vol.39, issue.1, pp.53-60, 2006.
DOI : 10.1016/j.bone.2005.12.078
URL : https://hal.archives-ouvertes.fr/inserm-00110462

F. Lézot, B. Thomas, C. Blin-wakkach, B. Castaneda, A. Bolanos et al., Dlx homeobox gene family expression in osteoclasts, Journal of Cellular Physiology, vol.275, pp.779-787, 2010.
DOI : 10.1002/jcp.22095

M. Baud-'huin, L. Duplomb, S. Téletchéa, C. Charrier, M. Maillasson et al., Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival, Journal of Biological Chemistry, vol.284, issue.46, pp.31704-31713, 2009.
DOI : 10.1074/jbc.M109.030312
URL : https://hal.archives-ouvertes.fr/inserm-00667507

L. Duplomb, M. Baud-'huin, C. Charrier, M. Berreur, V. Trichet et al., Phosphorylation of Signal Transducer and Activator of Transcription 3, Endocrinology, vol.149, issue.7, pp.3688-3697, 2008.
DOI : 10.1210/en.2007-1719
URL : https://hal.archives-ouvertes.fr/inserm-00667501

H. Knowles and N. Athanasou, Canonical and non-canonical pathways of osteoclast formation, Histol Histopathol, vol.24, pp.337-346, 2009.

Y. Kong, H. Yoshida, I. Sarosi, H. Tan, E. Timms et al., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, vol.397, pp.315-323, 1999.

M. Baud-'huin, R. R. Charrier, C. Riet, A. Moreau, A. Brion et al., Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis, The Journal of Pathology, vol.102, issue.1, pp.77-86, 2010.
DOI : 10.1002/path.2684

K. Chu, R. Snyder, M. Econs, and M. Facp, Disease Status in Autosomal Dominant Osteopetrosis Type 2 Is Determined by Osteoclastic Properties, Journal of Bone and Mineral Research, vol.19, issue.S2, pp.1089-1097, 2006.
DOI : 10.1359/jbmr.060409

K. Fuller, B. Kirstein, and T. J. Chambers, Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents, Endocrinology, vol.147, issue.4, pp.1979-1985, 2006.
DOI : 10.1210/en.2005-1340

M. Baud-'huin, C. Ruiz-velasco, G. Jego, C. Charrier, N. Gasiunas et al., Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption, Eur J Cell Biol, vol.60, pp.49-57, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00667533

F. Gouin, S. Couillaud, M. Cottrel, A. Godard, N. Passuti et al., PRESENCE OF LEUKAEMIA INHIBITORY FACTOR (LIF) AND LIF-RECEPTOR CHAIN (gp190) IN OSTEOCLAST-LIKE CELLS CULTURED FROM HUMAN GIANT CELL TUMOUR OF BONE. ULTRASTRUCTURAL DISTRIBUTION, Cytokine, vol.11, issue.4, pp.282-289, 1999.
DOI : 10.1006/cyto.1998.0429

J. Guicheux, D. Heymann, A. Rousselle, F. Gouin, P. Pilet et al., Growth Hormone Stimulatory Effects on Osteoclastic Resorption Are Partly Mediated by Insulin-like Growth Factor I: An In Vitro Study, Bone, vol.22, issue.1, pp.25-31, 1998.
DOI : 10.1016/S8756-3282(97)00224-X

A. Irie, M. Takami, H. Kubo, N. Sekino-suzuki, K. Kasahara et al., Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity, Bone, vol.41, issue.2, pp.165-174, 2007.
DOI : 10.1016/j.bone.2007.04.190

L. Ling, S. Murali, G. Stein, and . Van-wijnen, Glycosaminoglycans modulate RANKL-induced osteoclastogenesis, Journal of Cellular Biochemistry, vol.347, pp.1222-1231, 2010.
DOI : 10.1002/jcb.22506
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095103

S. Théoleyre, K. Tat, S. Vusio, P. Blanchard, F. Gallagher et al., Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor ??B ligand (RANKL) and RANK, Biochemical and Biophysical Research Communications, vol.347, issue.2, pp.460-467, 2006.
DOI : 10.1016/j.bbrc.2006.06.120

F. Lamoureux, G. Picarda, L. Garrigue-antar, M. Baud-'huin, V. Trichet et al., Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma, Cancer Research, vol.69, issue.2, pp.526-536, 2009.
DOI : 10.1158/0008-5472.CAN-08-2648

E. Chang, H. Kim, J. Ha, H. Kim, J. Ryu et al., Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4, Journal of Cell Science, vol.120, issue.1, pp.166-176, 2007.
DOI : 10.1242/jcs.03310
URL : http://jcs.biologists.org/cgi/content/short/jcs.03310v1

E. Pivetta, M. Scapolan, B. Wassermann, A. Steffan, A. Colombatti et al., Blood-derived human osteoclast resorption activity is impaired by Hyaluronan-CD44 engagement via a p38-dependent mechanism, Journal of Cellular Physiology, vol.13, issue.3, 2011.
DOI : 10.1002/jcp.22398

P. Spessotto, F. Rossi, M. Degan, D. Francia, R. Perris et al., Hyaluronan???CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9, The Journal of Cell Biology, vol.161, issue.6, pp.1133-1144, 2002.
DOI : 10.1172/JCI5481

K. Yamaguchi, M. Kinosaki, M. Goto, F. Kobayashi, E. Tsuda et al., Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor, Journal of Biological Chemistry, vol.273, issue.9, pp.5117-5123, 1998.
DOI : 10.1074/jbc.273.9.5117

T. Standal, C. Seidel, O. Hjertner, T. Plesner, R. Sanderson et al., Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells, Blood, vol.100, issue.8, pp.3002-3007, 2002.
DOI : 10.1182/blood-2002-04-1190

B. Mosheimer, N. Kaneider, C. Feistritzer, A. Djanani, D. Sturn et al., Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.5, pp.2964-2971, 2005.
DOI : 10.1210/jc.2004-1895

S. Cool and V. Nurcombe, The osteoblast-heparan sulfate axis: Control of the bone cell lineage, The International Journal of Biochemistry & Cell Biology, vol.37, issue.9, pp.1739-1745, 2005.
DOI : 10.1016/j.biocel.2005.03.006

J. Cao, P. Singleton, S. Majumdar, B. Boudignon, A. Burghardt et al., Hyaluronan Increases RANKL Expression in Bone Marrow Stromal Cells Through CD44, Journal of Bone and Mineral Research, vol.269, issue.1, pp.30-40, 2005.
DOI : 10.1359/JBMR.041014

C. Robinson, N. Harmer, S. Goodger, T. Blundell, and J. Gallagher, Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes, Journal of Biological Chemistry, vol.280, issue.51, pp.42274-42282, 2005.
DOI : 10.1074/jbc.M505720200

M. Presta, P. Dell-'era, S. Mitola, E. Moroni, R. Ronca et al., Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis, Cytokine & Growth Factor Reviews, vol.16, issue.2, pp.159-178, 2005.
DOI : 10.1016/j.cytogfr.2005.01.004

S. Song, S. Cool, and V. Nurcombe, Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2, Journal of Cellular Biochemistry, vol.13, issue.2, pp.402-411, 2007.
DOI : 10.1002/jcb.21068

L. Haupt, S. Murali, F. Mun, N. Teplyuk, L. Mei et al., The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis, Journal of Cellular Physiology, vol.281, issue.3, pp.780-791, 2009.
DOI : 10.1002/jcp.21825

S. Fox and A. Lovibond, Current insights into the role of transforming growth factor-?? in bone resorption, Molecular and Cellular Endocrinology, vol.243, issue.1-2, pp.19-26, 2005.
DOI : 10.1016/j.mce.2005.09.008

Y. Bi, C. Stuelten, T. Kilts, S. Wadhwa, R. Iozzo et al., Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells, Journal of Biological Chemistry, vol.280, issue.34, pp.30481-30489, 2005.
DOI : 10.1074/jbc.M500573200

Y. Bi, K. Nielsen, T. Kilts, A. Yoon, M. Karsdal et al., Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts, Bone, vol.38, issue.6, pp.30481-30489, 2006.
DOI : 10.1016/j.bone.2005.11.005

A. Kumarasuriyar, I. Lee, V. Nurcombe, and S. Cool, De-sulfation of MG-63 cell glycosaminoglycans delays in vitro osteogenesis, up-regulates cholesterol synthesis and disrupts cell cycle and the actin cytoskeleton, Journal of Cellular Physiology, vol.284, issue.3, pp.572-583, 2009.
DOI : 10.1002/jcp.21700

J. Muir, M. Andrew, J. Hirsh, J. Weitz, E. Young et al., Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo, Blood, vol.88, pp.1314-1320, 1996.

C. Ruiz-velasco, M. Baud-'huin, C. Sinquin, M. Maillasson, D. Heymann et al., Effects of a sulphated 'heparin-like' exopolysaccharide produced by Altermonas infernus on bone biology, Glycobiology, 2011.

P. Barton, A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry, Am J Obstet Gynecol, vol.170, pp.862-869, 1994.

J. Folwarczna, L. Sliwi?ski, W. Janiec, and M. Pikul, Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro, Pharmacol Rep, vol.57, pp.635-645, 2005.

R. Rajgopal, M. Bear, M. Butcher, and S. Shaughnessy, The effects of heparin and low molecular weight heparins on bone, Thrombosis Research, vol.122, issue.3, pp.293-298, 2008.
DOI : 10.1016/j.thromres.2006.10.025

K. Nakano, Y. Okada, K. Saito, and Y. Tanaka, Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts, Arthritis & Rheumatism, vol.16, issue.8, pp.2450-2458, 2004.
DOI : 10.1002/art.20367